BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
203 hedge funds and large institutions have $3.89B invested in Blueprint Medicines in 2019 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 66 increasing their positions, 59 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
12% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 59
6.03% more ownership
Funds ownership: 104.04% → 110.07% (+6%)
12% less call options, than puts
Call options by funds: $15.1M | Put options by funds: $17.1M
Holders
203
Holding in Top 10
11
Calls
$15.1M
Puts
$17.1M
Top Buyers
| 1 | +$33.1M | |
| 2 | +$28.3M | |
| 3 | +$27.8M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$23.7M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$21.1M |
Top Sellers
| 1 | -$43.4M | |
| 2 | -$40.5M | |
| 3 | -$16.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$16M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$14.8M |